SCHEMBL6856841

SCHEMBL6856841

Oc1ccccc1-c1nc2ccccc2o1.[Na]

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.79
KDM6B O15054 1/20 0.69
KDM6A O15550 1/20 0.69
PTGS2 P35354 2/20 0.58
ALDH1A1 P00352 5/20 0.54
HPGD P15428 5/20 0.54
MAPT P10636 5/20 0.54
KDM4E B2RXH2 4/20 0.54
USP2 O75604 2/20 0.54
TDP1 Q9NUW8 1/20 0.54
ESR1 P03372 5/20 0.53
ESR2 Q92731 5/20 0.53
NPC1 O15118 5/20 0.51
RAB9A P51151 5/20 0.51
HSD17B10 Q99714 4/20 0.51
TP53 P04637 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
PKM P14618 2/20 0.51
GLA P06280 1/20 0.51
GAA P10253 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL56592 0.98 TOP2A (0.82) TOP2AKDM6BKDM6APTGS2ALDH1A1
SCHEMBL29401377 0.98 TOP2A (0.82) TOP2AKDM6BKDM6APTGS2ALDH1A1
SCHEMBL1888141 0.96 TOP2A (0.79) TOP2AKDM6BKDM6APTGS2ALDH1A1
Lithium SCHEMBL6864068 0.96 TOP2A (0.79) TOP2AKDM6BKDM6APTGS2ALDH1A1
SCHEMBL17385621 0.96 TOP2A (0.79) TOP2AKDM6BKDM6APTGS2ALDH1A1
SCHEMBL1549736 0.96 TOP2A (0.79) TOP2AKDM6BKDM6APTGS2ALDH1A1
SCHEMBL1377496 0.96 TOP2A (0.79) TOP2AKDM6BKDM6APTGS2ALDH1A1
SCHEMBL1550650 0.96 TOP2A (0.79) TOP2AKDM6BKDM6APTGS2ALDH1A1
SCHEMBL1550613 0.96 TOP2A (0.79) TOP2AKDM6BKDM6APTGS2ALDH1A1
SCHEMBL1549620 0.96 TOP2A (0.79) TOP2AKDM6BKDM6APTGS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6800380-B2 BENZOXAZOLE- OR BENZTHIAZOLE-METAL COMPLEXES; HIGH THERMAL STABILITY: EMIT PURE BLUE LIGHT NESSDISPLAY CO., LTD. (KR) 2004-10-05 US disclosed
US-20030165711-A1 Novel organometallic luminescent materials and organic electroluminescent device containing same DONGJIN SEMICHEM CO., LTD. (KR) 2003-09-04 US disclosed
US-6579633-B2 Metal sulfonates of metal complexes of hydroxy- and mercapto-quinolines, benzoxazoles, benzothiazoles, benzotriazoles, benzoselenazoles, benzotellurazoles and phenanthridines NESSDISPLAY CO., LTD. (KR) 2003-06-17 US disclosed
US-6534201-B2 Metal sulfonates of metal complexes of hydroxy- and mercapto-quinolines, benzoxazoles, benzothiazoles, benzotriazoles, benzoselenazoles, benzotellurazoles and phenanthridines DONGJIN SEMICHEM CO., LTD. (KR) 2003-03-18 US disclosed
US-20020045063-A1 Novel organometallic luminescent materials and organic electroluminescent device containing same NESSDISPLAY CO., LTD. 2002-04-18 US disclosed
US-20020045064-A1 Novel organometallic luminescent materials and organic electroluminescent device containing same NESSDISPLAY CO., LTD. 2002-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030165711-A1 Novel organometallic luminescent materials and organic electroluminescent device containing same SOD1, MB, IK TOP2A 4443/4885KDM6B 2831/4885KDM6A 2874/4885
US-20020045063-A1 Novel organometallic luminescent materials and organic electroluminescent device containing same IK, LAGE3, NDUFV2 TOP2A 3287/4885KDM6B 2192/4885KDM6A 2094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.